Market Research Logo

Hospital Acquired Infections Market Analysis & Trends-Product (Specific Hospital Acquired Infections (Nosocomial) Disease Testing, Pseudomonas Aeruginosa, Acinetobacter Baumannii, Transmission Testing, Genotypic Methods, Drug-Resistance Testing) - Foreca

Hospital Acquired Infections Market Analysis & Trends-Product (Specific Hospital Acquired Infections (Nosocomial) Disease Testing, Pseudomonas Aeruginosa, Acinetobacter Baumannii, Transmission Testing, Genotypic Methods, Drug-Resistance Testing) - Forecast to 2025

The Global Hospital Acquired Infections Testing Market is poised to grow at a CAGR of around 19.1% over the next decade to reach approximately $2.75 billion by 2025. Some of the prominent trends that the market is witnessing include Government Regulations to Employ an Infection Control Practitioner for Every 200 Beds, Technological Improvements in Molecular Diagnostics Field and Implementation of Patient Care and Affordable Care Act in the U.S. Reduced Infections.

Based on Product the market is categorized into Specific Hospital Acquired Infections (Nosocomial) Disease Testing and Transmission Testing. Specific Hospital Acquired Infections (Nosocomial) Disease Testing is further segmented into Pseudomonas Aeruginosa, Acinetobacter Baumannii, Vancomycin-resistant Enterococcus, Clostridium Difficile, Urinary Tract Infections, Staphylococcus Aureus, Hospital-Acquired Pneumonia and Tuberculosis. Transmission Testing is further segmented into Genotypic Methods and Drug-Resistance Testing.

This industry report analyzes the global markets for Hospital Acquired Infections Testing across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

The Hospital Acquired Infections Testing Market report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:
North America
US
Canada
Mexico

Europe
France
Germany
Italy
Spain
UK
Rest of Europe

Asia Pacific
China
Japan
India
Australia
New Zealand
Rest of Asia

Middle East
Saudi Arabia
UAE
Rest of Middle East

Latin America
Argentina
Brazil
Rest of Latin America

Rest of the World
Africa
Caribbean

Report Highlights:
The report provides a detailed analysis on current and future market trends to identify the investment opportunities
Market forecasts till 2025, using estimated market values as the base numbers
Key market trends across the business segments, Regions and Countries
Key developments and strategies observed in the market
Market Dynamics such as Drivers, Restraints, Opportunities and other trends
In-depth company profiles of key players and upcoming prominent players
Growth prospects among the emerging nations through 2025
Market opportunities and recommendations for new investments


1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Strategic Benchmarking
1.6 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Implementation of Patient Care And Affordable Care Act In The U.S. Reduced Infections
3.1.2 Technological Improvements in Molecular Diagnostics Field
3.1.3 Government Regulations to Employ An Infection Control Practitioner For Every 200 Beds
3.1.4 Recent Techlological Developments of Hospital Acquired Infections Testing
3.1.5 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry
4 Hospital Acquired Infections Testing Market, By Product
4.1 Specific Hospital Acquired Infections (Nosocomial) Disease Testing
4.1.1 Specific Hospital Acquired Infections (Nosocomial) Disease Testing Market Forecast to 2025 (US$ MN)
4.1.1.1 Pseudomonas Aeruginosa
4.1.1.1.1 Pseudomonas Aeruginosa Market Forecast to 2025 (US$ MN)
4.1.1.2 Ventilator-Associated Pneumonia
4.1.1.2.1 Ventilator-Associated Pneumonia Market Forecast to 2025 (US$ MN)
4.1.1.3 Acinetobacter Baumannii
4.1.1.3.1 Acinetobacter Baumannii Market Forecast to 2025 (US$ MN)
4.1.1.4 Vancomycin-resistant Enterococcus
4.1.1.4.1 Vancomycin-resistant Enterococcus Market Forecast to 2025 (US$ MN)
4.1.1.5 Clostridium Difficile
4.1.1.5.1 Clostridium Difficile Market Forecast to 2025 (US$ MN)
4.1.1.6 Urinary Tract Infections
4.1.1.6.1 Urinary Tract Infections Market Forecast to 2025 (US$ MN)
4.1.1.7 Staphylococcus Aureus
4.1.1.7.1 Staphylococcus Aureus Market Forecast to 2025 (US$ MN)
4.1.1.8 Hospital-Acquired Pneumonia
4.1.1.8.1 Hospital-Acquired Pneumonia Market Forecast to 2025 (US$ MN)
4.1.1.9 Tuberculosis
4.1.1.9.1 Tuberculosis Market Forecast to 2025 (US$ MN)
4.2 Transmission Testing
4.2.1 TransmissionTesting Market Forecast to 2025 (US$ MN)
4.2.1.1 Genotypic Methods
4.2.1.1.1 Genotypic Methods Market Forecast to 2025 (US$ MN)
4.2.1.2 Drug-Resistance Testing
4.2.1.1.2 Drug-Resistance Testing Market Forecast to 2025 (US$ MN)
5 Hospital Acquired Infections Testing Market, By Geography
5.1 North America
5.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
5.1.1.1 US
5.1.1.2 Canada
5.1.1.3 Mexico
5.2 Europe
5.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
5.2.1.1 France
5.2.1.2 Germany
5.2.1.3 Italy
5.2.1.4 Spain
5.2.1.5 UK
5.2.1.5 Rest of Europe
5.3 Asia Pacific
5.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
5.3.1.1 China
5.3.1.2 Japan
5.3.1.3 India
5.3.1.4 Australia
5.3.1.5 New Zealand
5.3.1.5 Rest of Asia
5.4 Middle East
5.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
5.4.1.1 Saudi Arabia
5.4.1.2 UAE
5.4.1.3 Rest of Middle East
5.5 Latin America
5.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
5.5.1.1 Argentina
5.5.1.2 Brazil
5.5.1.3 Rest of Latin America
5.6 Rest of the World (RoW)
5.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
5.6.1.1 Africa
5.6.1.2 Caribbean
6 Key Player Activities
6.1 Mergers & Acquisitions
6.2 Partnerships, Joint Venture’s, Collaborations and Agreements
6.3 Product Launch & Expansions
6.4 Other Activities
7 Leading Companies
7.1 Gen-Probe
7.2 Siemens AG
7.3 Alere
7.4 Cephei
7.5 Roche
7.6 Abbott Laboratories
7.7 Qiagen GmbH
7.8 Becton, Dickinson
7.9 Meridian Bioscience, Inc.
7.10 bioMerieux
List of Tables
Table 1 Global Hospital Acquired Infections Testing Market By Region, Market Forecast (2013-2025) (US$ MN)
Table 2 Global Hospital Acquired Infections Testing Market By Product, Market Forecast (2013-2025) (US$ MN)
Table 3 Global Hospital Acquired Infections Testing Market By Specific Hospital Acquired Infections (Nosocomial) Disease Testing, Market Forecast (2013-2025) (US$ MN)
Table 4 Global Hospital Acquired Infections Testing Market By Pseudomonas Aeruginosa, Market Forecast (2013-2025) (US$ MN)
Table 5 Global Hospital Acquired Infections Testing Market By Ventilator-Associated Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 6 Global Hospital Acquired Infections Testing Market By Acinetobacter Baumannii, Market Forecast (2013-2025) (US$ MN)
Table 7 Global Hospital Acquired Infections Testing Market By Vancomycin-resistant Enterococcus, Market Forecast (2013-2025) (US$ MN)
Table 8 Global Hospital Acquired Infections Testing Market By Clostridium Difficile, Market Forecast (2013-2025) (US$ MN)
Table 9 Global Hospital Acquired Infections Testing Market By Urinary Tract Infections, Market Forecast (2013-2025) (US$ MN)
Table 10 Global Hospital Acquired Infections Testing Market By Staphylococcus Aureus, Market Forecast (2013-2025) (US$ MN)
Table 11 Global Hospital Acquired Infections Testing Market By Hospital-Acquired Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 12 Global Hospital Acquired Infections Testing Market By Tuberculosis, Market Forecast (2013-2025) (US$ MN)
Table 13 Global Hospital Acquired Infections Testing Market By Transmission Testing, Market Forecast (2013-2025) (US$ MN)
Table 14 Global Hospital Acquired Infections Testing Market By Genotypic Methods, Market Forecast (2013-2025) (US$ MN)
Table 15 Global Hospital Acquired Infections Testing Market By Drug-Resistance Testing, Market Forecast (2013-2025) (US$ MN)
Table 16 North America Hospital Acquired Infections Testing Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 17 North America Hospital Acquired Infections Testing Market By Product, Market Forecast (2013-2025) (US$ MN)
Table 18 North America Hospital Acquired Infections Testing Market By Specific Hospital Acquired Infections (Nosocomial) Disease Testing, Market Forecast (2013-2025) (US$ MN)
Table 19 North America Hospital Acquired Infections Testing Market By Pseudomonas Aeruginosa, Market Forecast (2013-2025) (US$ MN)
Table 20 North America Hospital Acquired Infections Testing Market By Ventilator-Associated Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 21 North America Hospital Acquired Infections Testing Market By Acinetobacter Baumannii, Market Forecast (2013-2025) (US$ MN)
Table 22 North America Hospital Acquired Infections Testing Market By Vancomycin-resistant Enterococcus, Market Forecast (2013-2025) (US$ MN)
Table 23 North America Hospital Acquired Infections Testing Market By Clostridium Difficile, Market Forecast (2013-2025) (US$ MN)
Table 24 North America Hospital Acquired Infections Testing Market By Urinary Tract Infections, Market Forecast (2013-2025) (US$ MN)
Table 25 North America Hospital Acquired Infections Testing Market By Staphylococcus Aureus, Market Forecast (2013-2025) (US$ MN)
Table 26 North America Hospital Acquired Infections Testing Market By Hospital-Acquired Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 27 North America Hospital Acquired Infections Testing Market By Tuberculosis, Market Forecast (2013-2025) (US$ MN)
Table 28 North America Hospital Acquired Infections Testing Market By Transmission Testing, Market Forecast (2013-2025) (US$ MN)
Table 29 North America Hospital Acquired Infections Testing Market By Genotypic Methods, Market Forecast (2013-2025) (US$ MN)
Table 30 North America Hospital Acquired Infections Testing Market By Drug-Resistance Testing, Market Forecast (2013-2025) (US$ MN)
Table 31 Europe Hospital Acquired Infections Testing Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 32 Europe Hospital Acquired Infections Testing Market By Product, Market Forecast (2013-2025) (US$ MN)
Table 33 Europe Hospital Acquired Infections Testing Market By Specific Hospital Acquired Infections (Nosocomial) Disease Testing, Market Forecast (2013-2025) (US$ MN)
Table 34 Europe Hospital Acquired Infections Testing Market By Pseudomonas Aeruginosa, Market Forecast (2013-2025) (US$ MN)
Table 35 Europe Hospital Acquired Infections Testing Market By Ventilator-Associated Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 36 Europe Hospital Acquired Infections Testing Market By Acinetobacter Baumannii, Market Forecast (2013-2025) (US$ MN)
Table 37 Europe Hospital Acquired Infections Testing Market By Vancomycin-resistant Enterococcus, Market Forecast (2013-2025) (US$ MN)
Table 38 Europe Hospital Acquired Infections Testing Market By Clostridium Difficile, Market Forecast (2013-2025) (US$ MN)
Table 39 Europe Hospital Acquired Infections Testing Market By Urinary Tract Infections, Market Forecast (2013-2025) (US$ MN)
Table 40 Europe Hospital Acquired Infections Testing Market By Staphylococcus Aureus, Market Forecast (2013-2025) (US$ MN)
Table 41 Europe Hospital Acquired Infections Testing Market By Hospital-Acquired Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 42 Europe Hospital Acquired Infections Testing Market By Tuberculosis, Market Forecast (2013-2025) (US$ MN)
Table 43 Europe Hospital Acquired Infections Testing Market By Transmission Testing, Market Forecast (2013-2025) (US$ MN)
Table 44 Europe Hospital Acquired Infections Testing Market By Genotypic Methods, Market Forecast (2013-2025) (US$ MN)
Table 45 Europe Hospital Acquired Infections Testing Market By Drug-Resistance Testing, Market Forecast (2013-2025) (US$ MN)
Table 46 Asia Pacific Hospital Acquired Infections Testing Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 47 Asia Pacific Hospital Acquired Infections Testing Market By Product, Market Forecast (2013-2025) (US$ MN)
Table 48 Asia Pacific Hospital Acquired Infections Testing Market By Specific Hospital Acquired Infections (Nosocomial) Disease Testing, Market Forecast (2013-2025) (US$ MN)
Table 49 Asia Pacific Hospital Acquired Infections Testing Market By Pseudomonas Aeruginosa, Market Forecast (2013-2025) (US$ MN)
Table 50 Asia Pacific Hospital Acquired Infections Testing Market By Ventilator-Associated Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 51 Asia Pacific Hospital Acquired Infections Testing Market By Acinetobacter Baumannii, Market Forecast (2013-2025) (US$ MN)
Table 52 Asia Pacific Hospital Acquired Infections Testing Market By Vancomycin-resistant Enterococcus, Market Forecast (2013-2025) (US$ MN)
Table 53 Asia Pacific Hospital Acquired Infections Testing Market By Clostridium Difficile, Market Forecast (2013-2025) (US$ MN)
Table 54 Asia Pacific Hospital Acquired Infections Testing Market By Urinary Tract Infections, Market Forecast (2013-2025) (US$ MN)
Table 55 Asia Pacific Hospital Acquired Infections Testing Market By Staphylococcus Aureus, Market Forecast (2013-2025) (US$ MN)
Table 56 Asia Pacific Hospital Acquired Infections Testing Market By Hospital-Acquired Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 57 Asia Pacific Hospital Acquired Infections Testing Market By Tuberculosis, Market Forecast (2013-2025) (US$ MN)
Table 58 Asia Pacific Hospital Acquired Infections Testing Market By Transmission Testing, Market Forecast (2013-2025) (US$ MN)
Table 59 Asia Pacific Hospital Acquired Infections Testing Market By Genotypic Methods, Market Forecast (2013-2025) (US$ MN)
Table 60 Asia Pacific Hospital Acquired Infections Testing Market By Drug-Resistance Testing, Market Forecast (2013-2025) (US$ MN)
Table 61 Middle East Hospital Acquired Infections Testing Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 62 Middle East Hospital Acquired Infections Testing Market By Product, Market Forecast (2013-2025) (US$ MN)
Table 63 Middle East Hospital Acquired Infections Testing Market By Specific Hospital Acquired Infections (Nosocomial) Disease Testing, Market Forecast (2013-2025) (US$ MN)
Table 64 Middle East Hospital Acquired Infections Testing Market By Pseudomonas Aeruginosa, Market Forecast (2013-2025) (US$ MN)
Table 65 Middle East Hospital Acquired Infections Testing Market By Ventilator-Associated Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 66 Middle East Hospital Acquired Infections Testing Market By Acinetobacter Baumannii, Market Forecast (2013-2025) (US$ MN)
Table 67 Middle East Hospital Acquired Infections Testing Market By Vancomycin-resistant Enterococcus, Market Forecast (2013-2025) (US$ MN)
Table 68 Middle East Hospital Acquired Infections Testing Market By Clostridium Difficile, Market Forecast (2013-2025) (US$ MN)
Table 69 Middle East Hospital Acquired Infections Testing Market By Urinary Tract Infections, Market Forecast (2013-2025) (US$ MN)
Table 70 Middle East Hospital Acquired Infections Testing Market By Staphylococcus Aureus, Market Forecast (2013-2025) (US$ MN)
Table 71 Middle East Hospital Acquired Infections Testing Market By Hospital-Acquired Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 72 Middle East Hospital Acquired Infections Testing Market By Tuberculosis, Market Forecast (2013-2025) (US$ MN)
Table 73 Middle East Hospital Acquired Infections Testing Market By Transmission Testing, Market Forecast (2013-2025) (US$ MN)
Table 74 Middle East Hospital Acquired Infections Testing Market By Genotypic Methods, Market Forecast (2013-2025) (US$ MN)
Table 75 Middle East Hospital Acquired Infections Testing Market By Drug-Resistance Testing, Market Forecast (2013-2025) (US$ MN)
Table 76 Latin America Hospital Acquired Infections Testing Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 77 Latin America Hospital Acquired Infections Testing Market By Product, Market Forecast (2013-2025) (US$ MN)
Table 78 Latin America Hospital Acquired Infections Testing Market By Specific Hospital Acquired Infections (Nosocomial) Disease Testing, Market Forecast (2013-2025) (US$ MN)
Table 79 Latin America Hospital Acquired Infections Testing Market By Pseudomonas Aeruginosa, Market Forecast (2013-2025) (US$ MN)
Table 80 Latin America Hospital Acquired Infections Testing Market By Ventilator-Associated Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 81 Latin America Hospital Acquired Infections Testing Market By Acinetobacter Baumannii, Market Forecast (2013-2025) (US$ MN)
Table 82 Latin America Hospital Acquired Infections Testing Market By Vancomycin-resistant Enterococcus, Market Forecast (2013-2025) (US$ MN)
Table 83 Latin America Hospital Acquired Infections Testing Market By Clostridium Difficile, Market Forecast (2013-2025) (US$ MN)
Table 84 Latin America Hospital Acquired Infections Testing Market By Urinary Tract Infections, Market Forecast (2013-2025) (US$ MN)
Table 85 Latin America Hospital Acquired Infections Testing Market By Staphylococcus Aureus, Market Forecast (2013-2025) (US$ MN)
Table 86 Latin America Hospital Acquired Infections Testing Market By Hospital-Acquired Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 87 Latin America Hospital Acquired Infections Testing Market By Tuberculosis, Market Forecast (2013-2025) (US$ MN)
Table 88 Latin America Hospital Acquired Infections Testing Market By Transmission Testing, Market Forecast (2013-2025) (US$ MN)
Table 89 Latin America Hospital Acquired Infections Testing Market By Genotypic Methods, Market Forecast (2013-2025) (US$ MN)
Table 90 Latin America Hospital Acquired Infections Testing Market By Drug-Resistance Testing, Market Forecast (2013-2025) (US$ MN)
Table 91 RoW Hospital Acquired Infections Testing Market By Country, Market Forecast (2013-2025) (US$ MN)
Table 92 RoW Hospital Acquired Infections Testing Market By Product, Market Forecast (2013-2025) (US$ MN)
Table 93 RoW Hospital Acquired Infections Testing Market By Specific Hospital Acquired Infections (Nosocomial) Disease Testing, Market Forecast (2013-2025) (US$ MN)
Table 94 RoW Hospital Acquired Infections Testing Market By Pseudomonas Aeruginosa, Market Forecast (2013-2025) (US$ MN)
Table 95 RoW Hospital Acquired Infections Testing Market By Ventilator-Associated Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 96 RoW Hospital Acquired Infections Testing Market By Acinetobacter Baumannii, Market Forecast (2013-2025) (US$ MN)
Table 97 RoW Hospital Acquired Infections Testing Market By Vancomycin-resistant Enterococcus, Market Forecast (2013-2025) (US$ MN)
Table 98 RoW Hospital Acquired Infections Testing Market By Clostridium Difficile, Market Forecast (2013-2025) (US$ MN)
Table 99 RoW Hospital Acquired Infections Testing Market By Urinary Tract Infections, Market Forecast (2013-2025) (US$ MN)
Table 100 RoW Hospital Acquired Infections Testing Market By Staphylococcus Aureus, Market Forecast (2013-2025) (US$ MN)
Table 101 RoW Hospital Acquired Infections Testing Market By Hospital-Acquired Pneumonia, Market Forecast (2013-2025) (US$ MN)
Table 102 RoW Hospital Acquired Infections Testing Market By Tuberculosis, Market Forecast (2013-2025) (US$ MN)
Table 103 RoW Hospital Acquired Infections Testing Market By Transmission Testing, Market Forecast (2013-2025) (US$ MN)
Table 104 RoW Hospital Acquired Infections Testing Market By Genotypic Methods, Market Forecast (2013-2025) (US$ MN)
Table 105 RoW Hospital Acquired Infections Testing Market By Drug-Resistance Testing, Market Forecast (2013-2025) (US$ MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report